Paul Horstmeier is COO at Health Catalyst, Inc. (HCAT). They have made 27 open-market trades across 1 company since 2020, most recently 2023-03-22.
CIK 0001780978
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCAT | 204,880 | $354K |
Shares reported on the most recent Form 4, priced at the 2023-03-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCAT | SELL | 2022-04-12 | 2022-04-14 | $25.16 | $262K | -25.4% | -38.2% | -33.4% |
| HCAT | SELL | 2022-03-09 | 2022-04-08 | $25.32 | $1.0M | -9.8% | -45.7% | -27.5% |
| HCAT | SELL · 10b5-1 | 2022-03-09 | 2022-03-11 | $25.31 | $587K | +8.3% | +6.3% | -37.4% |
| HCAT | SELL | 2022-02-07 | 2022-02-09 | $29.10 | $626K | -8.7% | -21.9% | -55.7% |
| HCAT | SELL | 2022-01-05 | 2022-01-06 | $36.78 | $791K | -15.2% | -16.9% | -28.3% |
| HCAT | SELL | 2021-12-07 | 2021-12-29 | $40.03 | $183K | -15.5% | -28.5% | -31.0% |
| HCAT | SELL | 2021-12-06 | 2021-12-29 | $39.27 | $453K | -15.5% | -28.5% | -31.0% |
| HCAT | SELL | 2021-11-05 | 2021-11-09 | $51.92 | $1.1M | -5.6% | -22.7% | -40.8% |
| HCAT | SELL | 2021-10-05 | 2021-10-07 | $48.06 | $985K | +2.3% | +6.3% | -26.9% |
| HCAT | SELL | 2021-09-07 | 2021-09-08 | $54.90 | $944K | -1.0% | -12.5% | -26.0% |
| HCAT | SELL | 2021-08-05 | 2021-08-09 | $55.80 | $1.2M | -10.7% | -2.7% | -6.5% |
| HCAT | SELL | 2021-07-06 | 2021-07-08 | $57.00 | $1.2M | -2.0% | +0.3% | -16.5% |
| HCAT | SELL | 2021-06-07 | 2021-06-09 | $55.46 | $897K | -2.1% | +0.9% | -4.9% |
| HCAT | SELL | 2021-05-05 | 2021-05-07 | $54.93 | $1.0M | -5.0% | +6.3% | +7.9% |
| HCAT | SELL | 2021-04-05 | 2021-04-08 | $48.09 | $279K | +5.3% | +2.9% | +16.4% |
| HCAT | SELL | 2021-03-05 | 2021-03-09 | $45.54 | $599K | -2.2% | +1.5% | +16.8% |
| HCAT | SELL | 2021-02-01 | 2021-02-03 | $49.44 | $1.1M | +6.5% | -7.2% | +12.2% |
| HCAT | SELL | 2021-01-04 | 2021-01-06 | $42.88 | $922K | +6.4% | +18.1% | +8.3% |
| HCAT | SELL | 2020-12-01 | 2020-12-03 | $35.12 | $1.4M | +5.2% | +16.6% | +29.4% |
| HCAT | SELL | 2020-11-02 | 2020-11-04 | $33.66 | $690K | -6.5% | +2.1% | +38.4% |
| HCAT | SELL | 2020-10-01 | 2020-10-02 | $36.42 | $783K | -3.0% | -6.7% | +19.2% |
| HCAT | SELL | 2020-09-01 | 2020-09-03 | $31.65 | $681K | +7.7% | +7.9% | +8.2% |
| HCAT | SELL | 2020-08-03 | 2020-08-05 | $35.51 | $767K | -10.9% | -11.7% | -2.1% |
| HCAT | SELL | 2020-07-01 | 2020-07-06 | $28.89 | $573K | +12.2% | +14.6% | +13.3% |
| HCAT | SELL | 2020-06-01 | 2020-06-03 | $26.97 | $432K | +3.6% | +11.7% | +14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.